How quickly does DBS take effect in Parkinson's disease?

Motor improvements are typically visible during intraoperative testing and continue to improve over 3–6 months as stimulation parameters are refined. Medication requirements usually decrease significantly.

Deep Brain Stimulation

Neurology

payments

Starting from

$16,000

Up to $60,000 depending on centre

schedule

Typical duration

10–21 days

Including pre-operative work-up

arrow_downwardlocal_hospital

Partner hospitals

Vetted for outcome data & accreditation

Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications

Overview

Neurosurgical implantation of electrodes into precise brain targets, connected to a subcutaneous pulse generator, to modulate abnormal neural circuits in movement disorders, psychiatric conditions, and chronic pain.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Pre-operative neurological assessment & brain MRI/CT

Functional neurosurgery team fees

DBS hardware (leads, extension cables, pulse generator)

Implantation surgery & intraoperative neurophysiology monitoring

Post-operative programming sessions

Interpreter & care coordinator

Long-term stimulator management plan at home

Deep Brain Stimulation

Coordinated from

$16,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Awake vs. Asleep (MRI-Guided) DBS Technique

Deep brain stimulation electrodes can be placed with the patient awake, using microelectrode recording and symptom testing to confirm the target, or with the patient asleep under general anaesthesia, using real-time interventional MRI guidance. Which technique is used, and whether it suits a given patient, is decided by the neurosurgical team — never a self-assessment.

Parameter	Awake (Microelectrode Recording)	Asleep (Interventional MRI-Guided)
Targeting approach	Relies on real-time microelectrode recording and the patient's conscious feedback during symptom testing to confirm the electrode is in the correct location, per a systematic review in the Journal of Neurosurgery.	Uses live interventional MRI imaging to confirm lead position while the patient is under general anaesthesia; a UCSF comparative study measured smaller average targeting errors and fewer lead passes with this approach.
Patient experience during surgery	The patient must remain conscious and cooperative for several hours, responding to symptom and side-effect testing under local anaesthesia at the pin sites.	Performed entirely under general anaesthesia, with no requirement for the patient to be awake or to respond to intraoperative testing.
Who it typically suits	Patients able to tolerate hours of conscious cooperation and off/on medication symptom testing during surgery, per published technical reviews.	Patients who cannot tolerate an awake procedure, and centres equipped with intraoperative MRI capability; the choice is made by the neurosurgical team, not the patient alone.
Clinical outcomes	Symptom improvement and effective stimulation settings are comparable to the asleep technique, per the same 2024 meta-analysis, despite the awake method requiring more lead-placement passes on average.	Despite differences in targeting technique, a 2024 systematic review and meta-analysis in the Journal of Neurosurgery found overall symptom improvement and stimulation thresholds were similar between the two approaches.
Candidacy assessment	Determined by a multidisciplinary movement-disorder team — a movement-disorder neurologist, neurosurgeon, neuropsychologist, and often a psychiatrist — never a self-diagnosis, per the National Institute of Neurological Disorders and Stroke (NINDS).	Uses the same multidisciplinary team-led evaluation process; the awake-vs-asleep decision is a technique choice made after candidacy is already confirmed.

The Procedure: Step by Step

The description below outlines the general deep brain stimulation process. Your movement-disorder neurology and neurosurgical team will confirm the specific steps and timeline for your case.

Multidisciplinary candidacy evaluation

A movement-disorder neurologist, neurosurgeon, neuropsychologist, and often a psychiatrist jointly assess diagnosis, medication response, brain imaging, and cognitive/psychiatric status to determine candidacy — this is a team clinical decision, not a self-assessment, per NINDS and published patient-selection guidelines.

Electrode implantation

Under local anaesthesia with the patient awake, or under general anaesthesia with real-time MRI guidance, the neurosurgeon places thin electrodes at the predetermined target deep in the brain, per Mayo Clinic Proceedings.

Pulse generator (IPG) placement

A pulse generator is implanted under the skin, typically below the collarbone, and connected to the brain electrodes by an extension wire tunneled under the skin of the scalp, neck, and shoulder; this may be done in the same operation or as a separate, often same-week, procedure, per Mayo Clinic Proceedings.

Device activation & programming

At a follow-up visit, typically some weeks after surgery, the neurologist switches on the pulse generator and begins programming the stimulation settings; this is refined over a series of follow-up visits as symptoms respond, per Cleveland Clinic.

Recovery Timeline

Overnight

Most patients spend one night in hospital after surgery for monitoring of complications such as seizure, confusion, or bleeding, per Cleveland Clinic and Mayo Clinic Proceedings.

Days–2 weeks

Light activities can typically resume within a few days; the surgical incisions are monitored for healing and checked at a follow-up visit, per Cleveland Clinic.

2–4 weeks

The pulse generator is switched on at an initial activation visit and programming begins; exact timing varies by centre and by condition being treated.

12–18 months

Maximum symptom benefit is generally reached only after a series of follow-up programming sessions, as settings are gradually adjusted; the pace and degree of improvement varies by individual, per Cleveland Clinic.

Source: Cleveland Clinic; Mayo Clinic Proceedings. Individual recovery and results vary and are guided by your neurology and neurosurgical team.

⚠

Known Risks & Limitations

Overall surgical morbidity for DBS is estimated at 3–4%, including hemorrhage, transient confusion, infection, and fracture, misplacement, or migration of the lead, per Mayo Clinic Proceedings; complication rates have declined over the past two decades as surgical experience has grown.
Intracerebral hemorrhage is an uncommon but serious risk, with symptomatic hemorrhage reported below 2% at experienced centres and perioperative hemorrhage of any kind around 1–2% in large single-centre case series, per the Journal of Neurosurgery and peer-reviewed complication studies.
Hardware-related infection is reported in roughly 3–7% of cases in large single-centre series, and can require partial or complete removal of the implanted hardware in the majority of infected cases, per peer-reviewed studies of DBS surgical and hardware complications.
Complication rates fall substantially as a surgical team's experience grows — one published single-centre study reported a drop from 23% in a surgeon's first 100 cases to 7% in their most recent 100 — so your team's DBS case volume is a reasonable question to raise.
DBS manages the symptoms of the underlying condition; it does not cure Parkinson's disease, essential tremor, or dystonia, or halt disease progression, and full symptom benefit is typically reached only after months of programming adjustments, per NINDS and Cleveland Clinic.

Source: Mayo Clinic Proceedings; Journal of Neurosurgery; National Institute of Neurological Disorders and Stroke (NINDS); peer-reviewed single- and multi-centre studies of deep brain stimulation surgical and hardware complications. No procedure is without risk; your neurology and neurosurgical team will review your individual case.

The CureSureMedico Care Pathway

Remote clinical review

Share your diagnosis, medication history, brain imaging, and, where relevant, video of your symptoms. Our coordination team forwards your case to a movement-disorder neurology and neurosurgery team, who assess candidacy and outline technique options.

Clinic matching & estimate

A consolidated cost estimate covering the multidisciplinary work-up, electrode and pulse-generator hardware, implantation surgery, and initial programming sessions is issued before you travel.

Travel & pre-operative work-up

On arrival, brain imaging, medication-response testing, and neuropsychological/psychiatric screening confirm final candidacy and the appropriate surgical technique ahead of surgery.

Procedure & early recovery

The electrode implantation and pulse-generator placement, whether combined or staged, followed by inpatient monitoring — typically one night in hospital — and discharge.

Continuity of care post-return

Initial device activation and first programming sessions are completed before you travel home. Programming settings and a discharge summary are shared with your home neurologist, with remote follow-up programming arranged for ongoing adjustments.

Treatment approaches

Standard and robotic-assisted Deep Brain Stimulation

Standard Approach

Frame-Based Stereotactic DBS Electrode Placement

$16,000

10–21 days

Robotic-Assisted Option

Robot-Assisted (ROSA) DBS Electrode Placement

$19,000

9–19 days

Comparing the two approaches

	Standard	Robotic-Assisted
Procedure	Frame-Based Stereotactic DBS Electrode Placement	Robot-Assisted (ROSA) DBS Electrode Placement
Technology	Conventional surgical instruments	Robotic-assisted surgical system with surgeon oversight
Availability	Hospital-dependent	Selected hospitals with robotic capability
Specialist	Procedure specialist	Specialist with relevant robotic experience
Clinical suitability	Case-dependent	Case-dependent
Tariff	$16,000–$60,000	$19,000–$66,000
Duration	10–21 days	9–19 days

Eligibility for robotic-assisted treatment

Movement-disorder or (at select centres) psychiatric DBS candidates confirmed by the neurology/neurosurgery team as suitable for stereotactic electrode implantation into a deep-brain target such as the STN, GPi, or VIM thalamus
A pre-surgical implantation plan with one or more precise electrode trajectories — the robotic platform's main benefit is speed and a frameless, more flexible trajectory setup, not a change to which patients qualify for DBS
Cross-sectional imaging (MRI, sometimes CT fusion) and multidisciplinary review confirming candidacy and a workable electrode trajectory plan
Availability of the robotic stereotactic platform (such as ROSA) and a functional neurosurgery team experienced with robot-assisted electrode placement at your selected hospital

Risks and limitations of robotic-assisted surgery

Robotic guidance applies specifically to planning and placing the electrodes accurately — it does not automate the procedure; a neurosurgeon still performs and directly oversees every step, including any awake intraoperative testing
Robotic assistance does not eliminate the risks of DBS electrode placement, including intracranial haemorrhage, infection, and hardware-related complications
Published comparisons show robot-assisted and frame-based DBS placement have comparable targeting accuracy (vector error roughly 1.5–1.8mm for both techniques), with the robotic approach mainly offering a frameless workflow and modestly shorter operating time rather than a clear safety advantage
The neurosurgeon remains responsible for trajectory planning and the safety of each electrode pass; robotic guidance is an aid to precision and workflow, not a substitute for surgical judgement

Tariff structure

Standard procedure$16,000–$60,000

Robotic-assisted technology fee+$3,000–$6,000

Total estimated robotic-assisted tariff$19,000–$66,000

Why can robotic-assisted procedures cost more?

Robotic-assisted procedures rely on additional technology and equipment beyond the standard operating platform and clinical team. This additional technology component is generally not included in standard case pricing.

Is robotic-assisted surgery always recommended?

No. Robotic-assisted surgery is not appropriate for every procedure or patient. Availability and suitability are determined by the treating specialist, based on your imaging, clinical condition, and the treating hospital's capabilities.

Global cost comparison — Deep Brain Stimulation

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

Country	Avg. cost	vs. cheapest
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi ✓ Verified	$21,600	+8%chevron_right
🇹🇷 Turkey Istanbul Best value✓ Verified	$20,000	—chevron_right
🇹🇭 Thailand Bangkok · Phuket · Chiang Mai ✓ Verified	$30,000	+50%chevron_right

Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.

Cost & recovery by procedure

This treatment category covers several different operations with different levels of invasiveness, recovery times, and costs. The country averages above blend all of them together — use the breakdown below for a more realistic, procedure-specific estimate.

DBS for Parkinson's Disease

Two thin electrodes are implanted into precise deep-brain targets — most commonly the subthalamic nucleus (STN) or globus pallidus interna (GPi) — and connected via subcutaneous extension wires to a pulse generator implanted under the skin of the chest, to reduce the tremor, rigidity, and motor fluctuations of Parkinson's disease.

Typical recovery · 4–6 weeks

Often staged: electrode implantation (awake or asleep, roughly 4–6 hours) is followed a few days to weeks later by pulse-generator placement under general anaesthesia. Hospital stay is typically 3–5 days across both stages. Most patients resume light activity within 4–6 weeks; stimulation programming begins 2–4 weeks after surgery and is fine-tuned over several follow-up visits. Risks include infection (roughly 3–5%) and intracranial bleeding (roughly 1–2%).

India

$15,000–$25,000

Turkey

$17,000–$28,000

Thailand